Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Current Drug Delivery|September 25, 2012
M-protein-derived conformational peptide epitope vaccine candidate against Group A StreptococcusMariusz Skwarczynski, Khairul A Kamaruzaman, Saranya Srinivasan, et al.
Journal of Medicinal Chemistry|September 15, 2012
Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenesMehfuz Zaman, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Plos One|January 19, 2012
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationshipMehfuz Zaman, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Chembiochem : a European Journal of Chemical Biology|January 12, 2017
Synthesis, Characterization and Immunological Evaluation of Self-Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting MoietiesVincent Fagan, Waleed M Hussein, Mei Su, et al.
NPJ Vaccines|May 9, 2018
Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacyManisha Pandey, Victoria Ozberk, Emma L Langshaw, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Comparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based VaccinesWaleed M Hussein, Saori Mukaida, Fazren Azmi, et al.
Vaccine|July 13, 2004
Identification and assessment of new vaccine candidates for group A streptococcal infectionsDavid J McMillan, Michael R Batzloff, Cindy L Browning, et al.
The Journal of Infectious Diseases|September 20, 2005
Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcusMichael R Batzloff, Huaru Yan, Mark R Davies, et al.
Plos Neglected Tropical Diseases|June 24, 2009
High burden of impetigo and scabies in a tropical countryAndrew C Steer, Adam W J Jenney, Joseph Kado, et al.
Vaccine|February 21, 2013
Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)Tania Rivera-Hernandez, Jon Hartas, Yang Wu, et al.
Pageof 8